Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced its engagement with ICON Clinical Research Limited ("ICON") to expand it's Phase II Clinical Trial for ...

Icon PLC (ICLR) on Wednesday reported second-quarter earnings of $183 million. On a per-share basis, the Dublin 18, Ireland-based company said it had profit of $2.30. Earnings, adjusted for one-time ...

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today reported its financial results for the second quarter ended June 30, 2025.